Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 1;20(10):1948-1954.
doi: 10.1093/pm/pny247.

Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain

Gabrielle F Miller  1 , Gery P Guy  2 , Kun Zhang  2 , Christina A Mikosz  2 , Likang Xu  1
Affiliations

Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain

Gabrielle F Miller et al. Pain Med. .

Abstract

Objective The increased use of opioids to treat chronic pain in the past 20 years has led to a drastic increase in opioid prescribing in the United States. The Centers for Disease Control and Prevention's (CDC's) Guideline for Prescribing Opioids for Chronic Pain recommends the use of nonopioid therapy as the preferred treatment for chronic pain. This study analyzes the prevalence of nonopioid prescribing among commercially insured patients with chronic pain. Design Data from the 2014 IBM® MarketScan® databases representing claims for commercially insured patients were used. International Classification of Diseases, Ninth Revision, codes were used to identify patients with chronic pain. Nonopioid prescriptions included nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics/antipyretics (e.g., acetaminophen), anticonvulsants, and antidepressant medications. The prevalence of nonopioid and opioid prescriptions was calculated by age, sex, insurance plan type, presence of a depressive or seizure disorder, and region. Results In 2014, among patients with chronic pain, 16% filled only an opioid, 17% filled only a nonopioid prescription, and 28% filled both a nonopioid and an opioid. NSAIDs and antidepressants were the most commonly prescribed nonopioids among patients with chronic pain. Having prescriptions for only nonopioids was more common among patients aged 50-64 years and among female patients. Conclusions This study provides a baseline snapshot of nonopioid prescriptions before the release of the CDC Guideline and can be used to examine the impact of the CDC Guideline and other evidence-based guidelines on nonopioid use among commercially insured patients with chronic pain.

Keywords: Chronic Pain; Drug Overdose; Nonopioids; Opioids.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflict of interest to declare. No financial disclosures were reported by the authors of this paper.

References

    1. Breuer B, Cruciani R, Portenoy RK. Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. Southern medical journal. 2010;103(8):738–47. - PubMed
    1. Pizzo PA, Clark NM. Alleviating suffering 101—pain relief in the United States. New England Journal of Medicine. 2012;366(3):197–9. - PubMed
    1. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long‐term opioid therapy for chronic non‐cancer pain. Pharmacoepidemiology and drug safety. 2009;18(12):1166–75. - PMC - PubMed
    1. Guy GP. Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morbidity and Mortality Weekly Report. 2017;66. - PMC - PubMed
    1. Paulozzi L, Jones C, Mack K, Rudd R. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999−−2008. MMWR Morbidity and mortality weekly report. 2011;60(43):1487. - PubMed

MeSH terms

Substances